12种抗真菌药物对来自伊朗、土耳其和中国头癣黄癣患者的55株许兰毛癣菌分离株的体外抗真菌药敏谱
In Vitro Antifungal Susceptibility Profiles of 12 Antifungal Drugs against 55 Trichophyton schoenleinii Isolates from Tinea Capitis Favosa Patients in Iran, Turkey, and China.
作者信息
Deng Shuwen, Ansari Saham, Ilkit Macit, Rafati Haleh, Hedayati Mohammad T, Taghizadeh-Armaki Mojtaba, Nasrollahi-Omran Ayatollah, Tolooe Ali, Zhan Ping, Liao Wanqing, van der Lee Henrich A, Verweij Paul E, Seyedmousavi Seyedmojtaba
机构信息
Shanghai Key Laboratory of Molecular Medical Mycology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
First Hospital of Xinjiang Medical University, Xinjiang, China.
出版信息
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01753-16. Print 2017 Feb.
Abstract
Trichophyton schoenleinii is an anthropophilic dermatophyte mainly causing tinea favosa of the scalp in certain regions of the world, especially Africa and Asia. We investigated the in vitro susceptibilities of 55 T. schoenleinii isolates collected over the last 30 years from Iran, Turkey, and China to 12 antifungals using the CLSI broth microdilution method. Our results revealed that terbinafine and ketoconazole were the most potent antifungal agents among those tested, independently of the geographic regions where strains were isolated.
摘要
许兰毛癣菌是一种亲人性皮肤癣菌，在世界某些地区，尤其是非洲和亚洲，主要引起头皮黄癣。我们采用美国临床和实验室标准协会（CLSI）肉汤微量稀释法，调查了过去30年从伊朗、土耳其和中国收集的55株许兰毛癣菌分离株对12种抗真菌药物的体外敏感性。我们的结果显示，在所测试的抗真菌药物中，特比萘芬和酮康唑是最有效的，与分离菌株的地理区域无关。
相似文献
1
In Vitro Antifungal Susceptibility Profiles of 12 Antifungal Drugs against 55 Trichophyton schoenleinii Isolates from Tinea Capitis Favosa Patients in Iran, Turkey, and China.
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01753-16. Print 2017 Feb.
2
Molecular epidemiology and in vitro antifungal susceptibility of Trichophyton schoenleinii, agent of tinea capitis favosa.
Mycoses. 2019 May;62(5):466-474. doi: 10.1111/myc.12889.
3
In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients.
J Antimicrob Chemother. 2015 Apr;70(4):1072-5. doi: 10.1093/jac/dku503. Epub 2014 Dec 9.
4
Tinea capitis favosa due to Trichophyton schoenleinii.
Acta Dermatovenerol Alp Pannonica Adriat. 2007 Mar;16(1):34-6.
5
In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Int J Dermatol. 2013 Dec;52(12):1557-60. doi: 10.1111/ijd.12100. Epub 2013 Oct 18.
6
: nucleotide sequence analysis and antifungal susceptibility testing of 40 clinical isolates.
J Med Microbiol. 2019 Nov;68(11):1655-1663. doi: 10.1099/jmm.0.001074. Epub 2019 Sep 25.
7
[A recurrent case of adult favus successfully treated with terbinafine].
Mikrobiyol Bul. 2015 Oct;49(4):619-24. doi: 10.5578/mb.9901.
8
Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Mycoses. 2005 May;48(3):205-10. doi: 10.1111/j.1439-0507.2005.01128.x.
9
Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling.
Mycopathologia. 2023 Oct;188(5):449-460. doi: 10.1007/s11046-022-00657-2. Epub 2022 Aug 18.
10
Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Indian J Med Microbiol. 2015 Oct-Dec;33(4):533-7. doi: 10.4103/0255-0857.167341.
引用本文的文献
1
Tinea capitis due to : A case of unusual laboratory finding on direct microscopic examination of infected hairs and skin lesions.
Med Mycol Case Rep. 2024 Feb 1;43:100629. doi: 10.1016/j.mmcr.2024.100629. eCollection 2024 Mar.
2
The in vitro Activity of Echinocandins Against Clinical Isolates and Review of the Susceptibility of to Echinocandins Worldwide.
Infect Drug Resist. 2023 Aug 18;16:5395-5403. doi: 10.2147/IDR.S423735. eCollection 2023.
3
Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling.
Mycopathologia. 2023 Oct;188(5):449-460. doi: 10.1007/s11046-022-00657-2. Epub 2022 Aug 18.
4
Molecular Mechanisms of 5-Fluorocytosine Resistance in Yeasts and Filamentous Fungi.
J Fungi (Basel). 2021 Oct 27;7(11):909. doi: 10.3390/jof7110909.
5
Molecular Identification and Antifungal Susceptibility Patterns of Dermatophytes Isolated from Companion Animals with Clinical Symptoms of Dermatophytosis.
J Vet Res. 2021 Apr 23;65(2):175-182. doi: 10.2478/jvetres-2021-0020. eCollection 2021 Jun.
6
Familial Cases of Trichophyton benhamiae Infection Transmitted from a Guinea Pig in Iran.
Mycopathologia. 2021 Mar;186(1):119-125. doi: 10.1007/s11046-020-00513-1. Epub 2021 Jan 4.
7
In-Vitro Activity of Nano Fluconazole and Conventional Fluconazole against Clinically Important Dermatophytes.
Iran J Public Health. 2020 Oct;49(10):1970-1976. doi: 10.18502/ijph.v49i10.4701.
8
Dermatophyte Resistance to Antifungal Drugs: Mechanisms and Prospectus.
Front Microbiol. 2018 May 29;9:1108. doi: 10.3389/fmicb.2018.01108. eCollection 2018.
本文引用的文献
1
Topical and systemic antifungals in dermatology practice.
Expert Rev Clin Pharmacol. 2017 Feb;10(2):225-237. doi: 10.1080/17512433.2017.1263564. Epub 2016 Dec 7.
2
Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran.
Mycopathologia. 2016 Feb;181(1-2):89-95. doi: 10.1007/s11046-015-9941-y. Epub 2015 Sep 14.
3
Epidemiological changes in tinea capitis over the sixty years of economic growth in China.
Med Mycol. 2015 Sep;53(7):691-8. doi: 10.1093/mmy/myv057. Epub 2015 Aug 10.
4
Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrum.
Antimicrob Agents Chemother. 2015 Jul;59(7):4312-4. doi: 10.1128/AAC.00244-15. Epub 2015 Apr 20.
5
In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients.
J Antimicrob Chemother. 2015 Apr;70(4):1072-5. doi: 10.1093/jac/dku503. Epub 2014 Dec 9.
6
British Association of Dermatologists' guidelines for the management of tinea capitis 2014.
Br J Dermatol. 2014 Sep;171(3):454-63. doi: 10.1111/bjd.13196.
7
In-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran.
Iran J Pharm Res. 2013 Summer;12(3):537-45.
8
Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study.
J Dtsch Dermatol Ges. 2013 Aug;11(8):737-41, 737-42. doi: 10.1111/ddg.12095. Epub 2013 Apr 10.
9
Tinea capitis favosa in a 73-year-old immunocompetent Tunisian woman.
Mycoses. 2012 Sep;55(5):454-6. doi: 10.1111/j.1439-0507.2011.02160.x. Epub 2012 Jan 12.
10
Favus of the scalp: an overview and update.
Mycopathologia. 2010 Sep;170(3):143-54. doi: 10.1007/s11046-010-9312-7. Epub 2010 Apr 22.
Zotero 插件